In: Medical & Biological Engineering & Computing, 2012, vol. 50, no. 2, p. 155-163
|
In: Basic Research in Cardiology, 2004, vol. 99, no. 4, p. 247-256
|
In: International Journal for Quality in Health Care, 2004, vol. 16, no. 5, p. 383-389
|
In: European Journal of Cardio-Thoracic Surgery, 2003, vol. 24, no. 5, p. 794-806
|
In: European Journal of Cardio-Thoracic Surgery, 2007, vol. 32, no. 1, p. 90-95
|
In: European Heart Journal, 2013, vol. 34, no. 35, p. 2739-2745
|
In: European Heart Journal, 2004, vol. 25, no. 16, p. 1438-1446
|
In: European Journal of Cardio-Thoracic Surgery, 2007, vol. 31, no. 1, p. 65-69
|
In: European Journal of Cardio-Thoracic Surgery, 2006, vol. 29, no. 5, p. 779-783
|
In: Basic Research in Cardiology, 2005, vol. 100(2), p. 102
Nitric oxide (NO) and monocyte chemoattractant protein–1 (MCP-1) exert partly opposing effects in vascular biology. NO plays pleiotropic vasoprotective roles including vasodilation and inhibition of platelet aggregation, smooth muscle cell proliferation, and endothelial monocyte adhesion, the last effect being mediated by MCP–1 downregulation. Early stages of arteriosclerosis are associated...
|